Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Jennifer Sue Temel, M.D.

Co-Author

This page shows the publications co-authored by Jennifer Temel and Inga Lennes.
Connection Strength

3.301
  1. Randomized Trial of a Smartphone Mobile App to Improve Symptoms and Adherence to Oral Therapy for Cancer. J Natl Compr Canc Netw. 2020 02; 18(2):133-141.
    View in: PubMed
    Score: 0.229
  2. The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer. Cancer. 2017 Dec 01; 123(23):4720-4727.
    View in: PubMed
    Score: 0.196
  3. Symptom burden to predict health care utilization in hospitalized patients with incurable cancer. J Clin Oncol. 2016 Oct 09; 34(26_suppl):98.
    View in: PubMed
    Score: 0.182
  4. Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of life. J Oncol Pract. 2015 May; 11(3):e405-12.
    View in: PubMed
    Score: 0.164
  5. Processes of discontinuing chemotherapy for metastatic non-small cell lung cancer at the end of life. J Clin Oncol. 2014 Nov; 32(31_suppl):96.
    View in: PubMed
    Score: 0.159
  6. Genotyping lung cancer is an investment in the future. J Clin Oncol. 2014 Nov 01; 32(31):3576-7.
    View in: PubMed
    Score: 0.157
  7. Perceptions of health status and survival in patients with metastatic lung cancer. J Pain Symptom Manage. 2014 Oct; 48(4):548-57.
    View in: PubMed
    Score: 0.153
  8. Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer. Cancer. 2014 Jan 15; 120(2):278-85.
    View in: PubMed
    Score: 0.148
  9. Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer. Palliat Support Care. 2013 Jun; 11(3):223-9.
    View in: PubMed
    Score: 0.141
  10. Electronic prompt to improve outpatient code status documentation for patients with advanced lung cancer. J Clin Oncol. 2013 Feb 20; 31(6):710-5.
    View in: PubMed
    Score: 0.140
  11. Predictors of newly diagnosed cancer patients' understanding of the goals of their care at initiation of chemotherapy. Cancer. 2013 Feb 01; 119(3):691-9.
    View in: PubMed
    Score: 0.138
  12. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012 Apr 20; 30(12):1310-5.
    View in: PubMed
    Score: 0.133
  13. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012 Feb 01; 30(4):394-400.
    View in: PubMed
    Score: 0.131
  14. Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer. Oncologist. 2011; 16(9):1299-306.
    View in: PubMed
    Score: 0.127
  15. ASCO Quality Oncology Practice Initiative (QOPI) quality measures for smoking cessation and survival in metastatic NSCLC. J Clin Oncol. 2011 May 20; 29(15_suppl):6074.
    View in: PubMed
    Score: 0.125
  16. Early palliative care, depression, and survival in metastatic NSCLC. J Clin Oncol. 2011 May 20; 29(15_suppl):6024.
    View in: PubMed
    Score: 0.125
  17. Effect of early palliative care on chemotherapy utilization and end-of-life care in patients with metastatic non-small cell lung cancer (NSCLC). J Clin Oncol. 2011 May 20; 29(15_suppl):6009.
    View in: PubMed
    Score: 0.125
  18. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011 Jun 10; 29(17):2319-26.
    View in: PubMed
    Score: 0.125
  19. Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations. JTO Clin Res Rep. 2021 Jan; 2(1):100124.
    View in: PubMed
    Score: 0.060
  20. Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life. J Natl Compr Canc Netw. 2019 03 01; 17(3):221-228.
    View in: PubMed
    Score: 0.054
  21. A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States. MDM Policy Pract. 2018 Jul-Dec; 3(2):2381468318801565.
    View in: PubMed
    Score: 0.052
  22. Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer. JCO Precis Oncol. 2018; 2018.
    View in: PubMed
    Score: 0.051
  23. Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy. Int J Radiat Oncol Biol Phys. 2017 May 01; 98(1):220.
    View in: PubMed
    Score: 0.047
  24. Treatment Satisfaction and Adherence to Oral Chemotherapy in Patients With Cancer. J Oncol Pract. 2017 05; 13(5):e474-e485.
    View in: PubMed
    Score: 0.047
  25. A Systematic Review of Adherence to Oral Antineoplastic Therapies. Oncologist. 2016 Mar; 21(3):354-76.
    View in: PubMed
    Score: 0.044
  26. Symptom burden in hospitalized patients with advanced cancer. J Clin Oncol. 2015 Oct 10; 33(29_suppl):100.
    View in: PubMed
    Score: 0.042
  27. Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life. Psychooncology. 2015 Dec; 24(12):1731-7.
    View in: PubMed
    Score: 0.041
  28. Documentation of oral versus intravenous chemotherapy plans in patients with metastatic non-small-cell lung cancer. J Oncol Pract. 2014 Mar; 10(2):e103-6.
    View in: PubMed
    Score: 0.038
  29. Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol. 2011 Dec; 22(12):2616-2624.
    View in: PubMed
    Score: 0.032
  30. Anxiety disorders in long-term survivors of adult cancers. Psychosomatics. 2011 Sep-Oct; 52(5):417-23.
    View in: PubMed
    Score: 0.032
  31. Phase II trial of carboplatin, abraxane, and bevacizumab in NSCLC. J Clin Oncol. 2011 May 20; 29(15_suppl):e18016.
    View in: PubMed
    Score: 0.031
  32. SNaPshot genotyping of non-small cell lung cancers (NSCLC) in clinical practice. J Clin Oncol. 2011 May 20; 29(15_suppl):7518.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.